Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
An insurmountable opportunity?
March 10, 2023
By: Emil W. Ciurczak
Independent Pharmaceuticals Professional
When I first suggested using Near-Infrared (NIR) for biological processes back in the late 1980s, I was told that they were very complex and there were too many components to “train” a NIR equation. My first response was that when the spectra stopped changing, the reaction was finished. One observation that I have made, with the aid of 20/20 hindsight, was the make-up of the staffs of a small molecule (SM) facility and a macro-molecule (biotech) facility. In short, the technical staff of a SM producer is quite varied, consisting of clinicians, organic chemists, analytical chemists, formulators, operators, and a host of other tech types. Basically, they employ chemists, pharmacists, and biochemists. When a process stream is being monitored, there are all disciplines available to help the production staff, each skilled in a different technology. In a biotech facility, the staff is largely homogeneous and steeped in biochemistry. That is, the basic R&D, scale-up, production, and analyses are almost all performed by scientists and technicians trained in the same biotech disciplines. This lack of diversity of disciplines almost precludes familiarity with all the newest technologies available for SM process control. That alone means a slower “warming” to “out-of-the-box” thinking for real time measurements by, for example, NIR, Raman, etc., which means slower adaptation to PAT or QbD. On top of that, the majority of the chemistry is the process. That is, in a SM process, the synthesis of the active is merely a first step in a long process. In Bio, this “synthesis” is the lion’s share of the process, with packaging being a freezing, freeze drying, etc. step. While I do not have formal training in the field of synthesizing/generating macromolecules, I have some familiarity with fermentations. I do remember, for example, that the source of the “catalyst” for fermentation can be as weird as the sludge from a brewery. In many cases, “natural” starter can not only vary from batch-to-batch, but even a 5-gallon pail varies within itself. In batch-fed fermentations, the classic method of bringing the fermentation to its maximum yield, was to take a sample from the reactor, analyze it, and either add more “food” or end the reaction and harvest the materials. The sampling was usually based on an SOP, wherein the sampling times were based on averages of past batches, not what was actually occurring in the fermentation. There are several problems with this approach: 1. The operator could be exposed to the bacteria (often e-Coli) or could expose the anaerobic reaction to oxygen or even contaminants. 2. The intermediate test could come too early or too late to be optimal, reducing the yield or causing side reactions. 3. The traditional off-line tests add time to the process, tying up equipment for extra hours. This means, to meet quotas, more equipment and operators are needed, causing the COGS (cost-of-goods-sold) to increase. That means charging more or having a lower profit margin. So, without major modification to the equipment or major capital outlays, what may be done to monitor the process in real time? I’m glad you asked. Every fermentation vessel has opening for adding materials, sampling the mixture, and, quite often, viewing ports. If we use Near Infrared or Raman spectroscopy, we can use a port to insert a fiber optic probe or view the reaction through the window. By a fortunate historical accident, NIRS was made “mainstream” by the U.S. Dept of Agriculture. By a rule in the CFR (Code of Federal Regulations), only stainless steel and sapphire are allowed to come in contact with foodstuffs. As a consequence, since USDA was the driving force in remote NIR measurements, stainless and sapphire became the de facto composition for fiber optic probes. That composition makes them quite useful for bioreactor monitoring: they are easily cleaned and unreactive with biological materials.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !